NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $243,000 | -93.3% | 2,876 | -92.7% | 0.05% | -91.7% |
| Q2 2021 | $3,604,000 | +10.0% | 39,500 | +3.0% | 0.64% | 0.0% |
| Q1 2021 | $3,277,000 | +18.5% | 38,334 | +30.9% | 0.64% | +14.6% |
| Q4 2020 | $2,765,000 | +10.8% | 29,284 | +2.0% | 0.56% | -19.5% |
| Q3 2020 | $2,496,000 | +0.5% | 28,703 | +0.9% | 0.70% | -15.6% |
| Q2 2020 | $2,484,000 | +3.2% | 28,442 | -2.5% | 0.82% | -24.7% |
| Q1 2020 | $2,406,000 | -34.4% | 29,186 | -24.6% | 1.10% | +16.5% |
| Q4 2019 | $3,666,000 | +9.3% | 38,713 | +0.3% | 0.94% | +1.6% |
| Q3 2019 | $3,353,000 | +16.0% | 38,581 | +21.9% | 0.92% | +15.0% |
| Q2 2019 | $2,890,000 | -19.4% | 31,646 | -15.1% | 0.80% | -22.9% |
| Q1 2019 | $3,584,000 | +13.2% | 37,278 | +1.0% | 1.04% | +0.3% |
| Q4 2018 | $3,167,000 | – | 36,912 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |